doi: 10.3389/fneur.2023.1056341 Received 28 September 2022 Accepted 02 January 2023 Published 16 January 2023 Volume 14 - 2023 Edited by Jian-Quan Shi, Nanjing Medical University, China Reviewed by Tomas Marek, Mayo Clinic, United States
this combination of techniques may give refined spatial resolution (83, 84)
Each treatment targets different aspects of the problem, which may explain why some people experience better results with both
The blend is also referred to in some catalogs as KLOW-80 or KLOW 80mg, which all point to the same vial composition
This is a practical consideration rather than an evidence-based recommendation, and should be discussed with the prescriber or trial team
Between 35-80% of people with PCOS are insulin resistant, meaning this hormone doesnt function as intended